`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`CLARKSBURG DIVISION
`
`
`
`
`
`
`Plaintiff,
`
`
`v.
`
`
`REGENERON PHARMACEUTICALS, INC.,
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`
`
`
`
`
`
`Defendant.
`
`
`
`Case No. 1:22-cv-00061-TSK
`
`JURY TRIAL DEMANDED
`
`
`
`REGENERON’S STIPULATION REGARDING
`CASE NARROWING AND INJUNCTIVE RELIEF
`
`Pursuant to the Court’s Scheduling Order (ECF 87), Regeneron hereby elects six patents
`
`from three patent families to proceed in the first stage of litigation, to which the deadlines in the
`
`Scheduling Order (ECF 87) apply. The six patents are:
`
`1. 10,888,601
`
`2. 11,053,280
`
`3. 11,084,865
`
`4. 11,104,715
`
`5. 11,253,572
`
`6. 11,299,532
`
`Furthermore, pursuant to the Court’s Scheduling Order, Regeneron hereby stipulates that
`
`it will not, with respect to the eighteen patents asserted in its Complaint (ECF 1) but not listed
`
`above, seek injunctive relief with respect to the United States marketing or sales of Mylan
`
`Pharmaceuticals Inc.’s current aBLA product (BLA No. 761274).
`
`
`
`1
`
`APOTEX V. REGENERON IPR2022-01524
`REGENERON EXHIBIT 2017 PAGE 001
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 88 Filed 10/28/22 Page 2 of 3 PageID #: 2218
`
`Date: October 28, 2022
`
`CAREY DOUGLAS KESSLER & RUBY PLLC
`
`/s/ Steven R. Ruby
`Steven R. Ruby (WVSB No. 10752)
`David R. Pogue (WVSB No. 10806)
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25323
`(304) 345-1234
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`
`Of Counsel:
`
`David I. Berl (admitted PHV)
`Ellen E. Oberwetter (admitted PHV)
`Thomas S. Fletcher (admitted PHV)
`Andrew V. Trask (admitted PHV)
`Teagan J. Gregory (admitted PHV)
`Shaun P. Mahaffy (admitted PHV)
`Arthur J. Argall III (admitted PHV)
`Adam Pan (admitted PHV)
`Nicholas Jordan (admitted PHV)
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`(202) 434-5000
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`aargall@wc.com
`apan@wc.com
`njordan@wc.com
`
`Counsel for Plaintiff Regeneron Pharmaceuticals, Inc.
`
`2
`
`APOTEX V. REGENERON IPR2022-01524
`REGENERON EXHIBIT 2017 PAGE 002
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 88 Filed 10/28/22 Page 3 of 3 PageID #: 2219
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on October 28, 2022, I electronically filed the foregoing with the
`
`Clerk of the Court by using the Court’s CM/ECF system. Counsel of record for all parties will
`
`be served by the Court’s CM/ECF system.
`
`
`
`
`
`
`
`
`
`/s/ Steven R. Ruby
`Steven R. Ruby
`
`
`
`
`
`3
`
`APOTEX V. REGENERON IPR2022-01524
`REGENERON EXHIBIT 2017 PAGE 003
`
`